Nicholas R. Glover's most recent trade in MEI Pharma Inc was a trade of 20,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MEI Pharma Inc | Nicholas R. Glover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2025 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| MEI Pharma Inc | Nicholas R. Glover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 87,500 | 87,500 | - | - | Stock Option (Right to Buy) | |
| MEI Pharma Inc | Nicholas R. Glover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) |